Rituximab binds specifically to a cell-surface marker known as CD20, found on developing B cells and mature B cells, but not on stem cells or plasma cells. When rituximab binds to CD20, it triggers mechanisms that result in targeting this select B cell population
download full resolution image
Copyright © F. Hoffmann-La Roche Ltd.
Not for use by photo stock agencies.